|
The Cochrane Stroke Group seeks to identify and review all randomised controlled trials (RCTs) and controlled clinical trials (CCTs) of interventions in the primary and secondary prevention of stroke, and the treatment and rehabilitation of stroke patients, including subarachnoid haemorrhage. Primary prevention trials are restricted to those in which stroke is the major outcome of interest, eg carotid surgery for asymptomatic stenosis. The primary prevention of generalised vascular disease is beyond the scope of the Cochrane Stroke Group, as is the primary prevention of stroke in patients with cardiac disease, eg stroke following myocardial infarction/cardiac surgery.
|